Structural changes affecting the skin, muscles, ligaments, fat, and bone get noticeable on an individual’s face due to decrease in cellular functions with aging. The inevitable physiological process of aging is generally not conceived positively by many, which, in turn, urges them to indulge in cosmetic rejuvenation procedures to remain youthful visually. Botulinum toxin (BOTA)—which is naturally produced by Clostridium botulinum—is the most popular neurotoxin used in cosmetic procedures. Therefore, the rising popularity of cosmetic procedures involving neurotoxins to reduce facial wrinkles while ensuring safety, effectivity, and efficiency is catalyzing the market for neurotoxins.
The Asia Pacific neurotoxin market is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. The increasing product developments and launches, growing numbers of aesthetic procedures, rising distribution by companies for neurotoxin products, and increasing demand for non-surgical aesthetic procedures among the young population are driving the growth of the market in the region. The Australian neurotoxin market is expected to have growth opportunities due to growing developments in the pharmaceutical industry. The country has several facilities, such as manufacturing, research and development, and a good distribution network. Also, the country is among the region's top countries performing aesthetic procedures. However, the market for neurotoxins is highly regulated in the country. The botulinum toxin products are classified as S4 pharmaceuticals; hence they are only administered by a doctor or a nurse. Also, the regulatory bodies strictly regulate the products in the country, and the brands approved by Therapeutic Goods Administration (TGA) in Australia are Botox, Dysport, and Xeomin.
Asia Pacific Neurotoxins Market Segmentation
The Asia Pacific neurotoxins market is segmented into product type, application, end user, and country.
Based on product type, the Asia Pacific neurotoxins market is subsegmented into botox, dysport, xenomin, and others. The botox segment registered the largest market share in 2023.
Based on application, the Asia Pacific neurotoxins market is segmented into therapeutic and aesthetic. The therapeutic segment held a larger market share in 2023.
Based on end user, the market is segmented into hospitals, specialty clinics, dermatology clinics, and others. The hospitals segment held the largest market share in 2023.
Based on country, the market is segmented into China, India, Japan, South Korea, Australia, and the rest of Asia Pacific. Japan dominated the market share in 2023.
AbbVie Inc, Gufic, Hugel Inc, Ipsen SA, Lanzhou Institute of Biological Products Co Ltd, Medytox Inc, and Merz Pharma GmbH & Co KGaA are among the leading companies operating in the Asia Pacific neurotoxins market.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 925.29 Million |
| Market Size by 2028 | US$ 1,858.41 Million |
| CAGR (2023 - 2028) | 15.0% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2028 |
| Segments Covered |
By Product Type
|
|
Regions and Countries Covered
|
|
| Asia-Pacific | China, India, Japan, Australia, Rest of Asia-Pacific |
| Market leaders and key company profiles |
|
The Asia Pacific Neurotoxins Market is valued at US$ 925.29 Million in 2023, it is projected to reach US$ 1,858.41 Million by 2028.
As per our report Asia Pacific Neurotoxins Market, the market size is valued at US$ 925.29 Million in 2023, projecting it to reach US$ 1,858.41 Million by 2028. This translates to a CAGR of approximately 15.0% during the forecast period.
The Asia Pacific Neurotoxins Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Neurotoxins Market report:
The Asia Pacific Neurotoxins Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Neurotoxins Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Neurotoxins Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+1 646 791 7070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Neurotoxins Market
